Previous Close | 8.59 |
Open | 8.60 |
Bid | 8.45 x 0 |
Ask | 8.66 x 0 |
Day's Range | 8.50 - 8.60 |
52 Week Range | 7.03 - 9.26 |
Volume | |
Avg. Volume | 6,032 |
Market Cap | 98.646M |
Beta (5Y Monthly) | 0.93 |
PE Ratio (TTM) | 16.04 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.18 (2.12%) |
Ex-Dividend Date | Feb 28, 2024 |
1y Target Est | N/A |
MISSISSAUGA, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2024 on Thursday, May 16, 2024 after market hours. A presentation on the Company’s first quarter 2024 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “R
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las ...
MISSISSAUGA, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th – May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent, will attend a Fireside Q&A session for investors at the conference on Wednesday, May 1st at 2:30pm PDT. Mr. Goehrum will also be available to meet with investors on a one-on-one basis during th